Article

Flash mob for a cure

Author(s):

Elizabeth Whittington

Before the Susan G. Komen Race for the Cure in Ohio this past Saturday, a flash mob comprised of doctors, researchers, nurses, staff, OSU students and cancer survivors broke out into dance to "Dancing in the Streets."I love a good flash mob dance. And while flash mobs are becoming more frequent and elaborate, the fact that some of these people are actively trying to cure cancer really makes me want to share this video with you.The flash mob included about 200 people associated with the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, including the cancer center's director, Dr. Michael Caligiuri. (The back flips and pyramids at the end were donated from the Ohio State Spirit Program, I believe. If not, I'm doubly impressed.) And after that three-minute dance routine, they ran the 5K. Whew!You can read more on the OSUCCC-James flash mob here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Related Content
A resilience program for young people with advanced cancer helped patients cope and led to a better quality of life: © stock.adobe.com.
July 31st 2025

How Resilience Coaching May Help Young People With Advanced Cancer

Spencer Feldman
A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life after 6 to 12 months.
The Importance of Spotting Endometrial Cancer
July 31st 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Carla Deschamps is now a survivor of colon cancer after receiving her diagnosis in February 2020. Read Carla's blogs here!
July 31st 2025

Can Journaling Help Heal After a Cancer Diagnosis?

Carla Deschamps
Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
July 31st 2025

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of lungs.
July 31st 2025

July Lung Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and patient-centered perspectives.
Jaypirca led to better response rates than Imbruvica in some previously treated patients with CLL/SLL: © stock.adobe.com.
July 31st 2025

Jaypirca Shows Improvements Over Imbruvica in CLL/SLL

Spencer Feldman
Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.